| 注册
首页|期刊导航|中国药物评价|对药品中芦荟苷含量测定的改进建议

对药品中芦荟苷含量测定的改进建议

吴旭

中国药物评价2018,Vol.35Issue(6):432-434,3.
中国药物评价2018,Vol.35Issue(6):432-434,3.

对药品中芦荟苷含量测定的改进建议

Suggestions for Improvement of Determination of Barbaloin Content in Pharmaceutical Products

吴旭1

作者信息

  • 1. 淮安市食品药品检验所,江苏 淮安 223300
  • 折叠

摘要

Abstract

Objective:To explore the problems encountered in the determination of barbaloin in Chinese medicines and then we put forward some suggestions.Methods:The problems encountered in the determination of barbaloin by HPLC-MS/MS were studied and analyzed.Results:Barbaloin was a mixture of barbaloin A and barbaloin B, butbarbaloin A was only detected in the existing assays.So some drugs were unqualified.Conclusion:It is suggested that the determination method of barbaloin in medicines should be further studied to improve the detection ability and quality standard.

关键词

HPLC-MS/MS法/芦荟苷/芦荟苷A/芦荟苷B

Key words

HPLC-MS/MS/Barbaloin/Barbaloin A/Barbaloin B

分类

医药卫生

引用本文复制引用

吴旭..对药品中芦荟苷含量测定的改进建议[J].中国药物评价,2018,35(6):432-434,3.

中国药物评价

2095-3593

访问量0
|
下载量0
段落导航相关论文